Redistribution of UK’s portfolio of centrally authorised products

April 11, 2018 – The EU27 Member States and the European Medicines Agency (EMA) have completed the reallocation of the medicines for which the United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) and Veterinary Medicines Directorate (VMD) are currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine. Over 370 centrally authorised products have been transferred to … (leggi tutto)